Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
-14.5%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 27.37% |
| 2024 | -2.15% |
| 2023 | -4.49% |
| 2022 | -21.92% |
| 2021 | 32.41% |
| 2020 | 60.00% |
| 2019 | 61.76% |
| 2018 | 86.35% |
| 2017 | 44.72% |
| 2016 | -23.91% |